BlackRock Inc. trimmed its stake in shares of Minerva Neurosciences (NASDAQ:NERV) by 3.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,018,778 shares of the biopharmaceutical company's …
Link to Full Article: Read Here
